Member of the Board of Directors, reporting to the company CEOPreclinical development global responsibilities: • Managing non-clinical development strategy for innovative therapeutic candidates through different stages of development (recombinant proteins, glycolipids) • Designing and managing GLP and non-GLP non-clinical drug development• Coordinating all related activities (costs, timing, and risk management) and direct overview & management of outsourced activities (CROs, academic collaborations) • Preparing key project documentation for Regulatory submissions (INDs in Europe, America, Asia, South Africa) and maintaining update knowledge of EMA, FDA and ICH guidance's and regulatory requirementsAchieved non-clinical development program for recombinant Interleukin-7 up to phase II and for Alpha-C-galactosyl Ceramide to early stage, 9 publications in international reviews Legal department (I.P. & Contracts) responsibilities: - Intellectual Property: • Managed Patent portfolio and provided strategic decisions for patenting• Performed prior art searches, oversaw competing patent survey and patents analysis• Worked collaboratively with patent attorney to respond to office actionsCo-inventor of 3 patents on Interleukin-7 among which 2 main patents granted worldwide- Contracts:• Managed R&D Contract portfolio until contract close-out• Prepared proposals, reviewed, negotiated and managed contracts (CDA, MTA, CTA, licensing contracts) in line with company strategic objectives and project requirements• Worked with the company senior management team and proactively engaged Clinical, Regulatory, Manufacturing and Business Development teamsWin-win approach, worldwide activity, Resolve disputes (100% amiable)Work independently and as part of a team with rapidly changing deadlines and priorities

• On behalf of LVMH Company Fragrances and Cosmetics, conducted a Feasibility evaluation of Industrial project. Implementation of High-Throughput Screening (HTS) technologies for chemical and biological discovery. Performed biological and I.P. state in the art Provided strategic and scientific advice and developed requirementsExpertise acquired industrial project management field• Under the supervision of D. GUERRE (I.P. Attorney, Lyon, France), co-redacted an industrial property guidebook applied to biotechnologies compliant with ESABIO I.P. Education Expertise acquired in Intellectual Property field

“Thrombosis Risk and Haemostasis Mechanisms” Laboratory (Dir.: Pr. M. AIACH)Research project “Expression in eukaryotic system of Factor X mutants”: Performed construction of Factor X mutants, Transfection in eukaryote systems, Expression, purification and characterization of recombinant molecules and monoclonal antibodiesAcquired expertise in the fields of molecular biology, cell culture, biochemistry and biotechnology

Genetic Molecular LaboratoryResearch project “Neurofibromatosis Type I (NFI) genetic disease”: Involved in research projects for direct and indirect diagnostics. Implemented automated molecular biology technological platforms. Involved in scientific team coordination (students and guest researchers). Implemented GLP/QA-QC policiesAcquired expertise in the fields of molecular biology, genetics and biotechnology - 10 publications in international reviews